(Q34089071)

30 July 2017

1 reference

title

Natural HPV immunity and vaccination strategies (English)

1 reference

ORCID Public Data File 2021

30 July 2017

1 reference

author name string

Stern PL

1

1 reference

30 July 2017

Brown M

2

1 reference

30 July 2017

Stacey SN

3

1 reference

30 July 2017

Kitchener HC

4

1 reference

30 July 2017

Hampson I

5

1 reference

30 July 2017

Abdel-Hady ES

6

1 reference

30 July 2017

Moore JV

7

1 reference

30 July 2017

publication date

1 October 2000

1 reference

Journal of Clinical Virology

30 July 2017

published in

1 reference

30 July 2017

volume

19

1 reference

30 July 2017

issue

1-2

1 reference

30 July 2017

page(s)

57-66

1 reference

A survey of seroprevalence of human papillomavirus types 16, 18 and 33 among children

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Correlation of T-helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Status of local cellular immunity in interferon-responsive and -nonresponsive human papillomavirus-associated lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Human papillomavirus type 16 E2-specific T-helper lymphocyte responses in patients with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Multiple mechanisms underlie HLA dysregulation in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Immunological events in regressing genital warts

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Evaluation of Langerhans' cells in the cervical epithelium of women with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Immunoglobulin G responses against human papillomavirus type 16 virus-like particles in a prospective nonintervention cohort study of women with cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Nasal immunization of mice with human papillomavirus type 16 (HPV-16) virus-like particles or with the HPV-16 L1 gene elicits specific cytotoxic T lymphocytes in vaginal draining lymph nodes

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Natural adjuvants: endogenous activators of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Cervical dysplasia in HIV-seropositive women: role of human papillomavirus infection and immune status

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Vulvar intraepithelial neoplasia: long term follow up of treated and untreated women.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

The immune system evolved to discriminate infectious nonself from noninfectious self

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Trends in squamous cell carcinoma of the vulva: the influence of vulvar intraepithelial neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Lymphoproliferative responses to human papillomavirus (HPV) type 16 proteins E6 and E7: outcome of HPV infection and associated neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Virus-like particles of bovine papillomavirus type 4 in prophylactic and therapeutic immunization

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Detection of genital human papillomavirus and associated cytological abnormalities among college women

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Detection of serologic neutralizing antibodies against HPV-11 in patients with condyloma acuminata and cervical dysplasia using an in vitro assay

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

CD28/B7 system of T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Loop diathermy excision of the cervical transformation zone in patients with abnormal cervical smears

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Papillomavirus lesions in immunodepression and immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Tolerance, danger, and the extended family

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

An innate sense of danger

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Innate immunity: the virtues of a nonclonal system of recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

The antigen-presenting environment in normal and human papillomavirus (HPV)-related premalignant cervical epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Chimeric papillomavirus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Papillomavirus virus-like particles can deliver defined CTL epitopes to the MHC class I pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: induction of cytotoxic T cells and specific tumor protection

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Papillomavirus-like particle vaccines for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Interferon treatment of human genital papillomavirus infection: importance of viral type

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Proliferative T cell responses to human papillomavirus type 16 L1 peptides in patients with cervical dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

Predicting mortality from cervical cancer after negative smear test results

1 reference

https://api.crossref.org/works/10.1016%2FS1386-6532%2800%2900128-1

7 January 2021

10.1016/S1386-6532(00)00128-1

Identifiers

DOI

1 reference

30 July 2017

1 reference